New decision aid for treatment of herniated disc beneficial

New decision aid for treatment of herniated disc beneficial
A new patient decision instrument meets the criteria of acceptability, reliability, and validity, and improves the quality of patient decision-making for treatment for a herniated disc, according to a study published in the Aug. 15 issue of Spine.

(HealthDay)—A new patient decision instrument meets the criteria of acceptability, reliability, and validity, and improves the quality of patient decision-making for treatment of a herniated disc, according to a study published in the Aug. 15 issue of Spine.

Karen R. Sepucha, Ph.D., from Massachusetts General Hospital in Boston, and colleagues developed and evaluated a -decision quality instrument (HD-DQI). The instrument generates two scores—a total knowledge score and a concordance score—each scaled 0 to 100 percent, with higher scores indicating better quality.

The researchers found that the HD-DQI survey was feasible for implementation and acceptable to patients. There were good response rates and limited missing data. The knowledge score was able to differentiate significantly between patients who had seen a decision aid or not (55 versus 38 percent) and between providers and patients (73 versus 46 percent). There was also good retest reliability (intraclass correlation coefficient, 0.85) with the knowledge score. The majority of patients (78 percent) were given treatments that matched their goals, and these patients were significantly less likely to regret their decision than those whose treatments did not match their goals (13 versus 39 percent).

"The HD-DQI met several criteria for high-quality patient-reported survey instruments," the authors write. "More work is needed to examine acceptability for use as part of routine patient care."

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Who will benefit from stroke drug? New score can help decide

Feb 06, 2012

A new scoring method can help doctors quickly decide which stroke patients will respond well to the clot-busting drug alteplase, according to a study published in the February 7, 2012, print issue of Neurology, the medica ...

Recommended for you

What are the chances that your dad isn't your dad?

Apr 16, 2014

How confident are you that the man you call dad is really your biological father? If you believe some of the most commonly-quoted figures, you could be forgiven for not being very confident at all. But how ...

New technology that is revealing the science of chewing

Apr 15, 2014

CSIRO's 3D mastication modelling, demonstrated for the first time in Melbourne today, is starting to provide researchers with new understanding of how to reduce salt, sugar and fat in food products, as well ...

After skin cancer, removable model replaces real ear

Apr 11, 2014

(HealthDay)—During his 10-year struggle with basal cell carcinoma, Henry Fiorentini emerged minus his right ear, and minus the hearing that goes with it. The good news: Today, the 56-year-old IT programmer ...

Italy scraps ban on donor-assisted reproduction

Apr 09, 2014

Italy's Constitutional Court on Wednesday struck down a Catholic Church-backed ban against assisted reproduction with sperm or egg donors that has forced thousands of sterile couples to seek help abroad.

User comments